Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating Biomarkers for Therapeutic Monitoring of Anti-cancer Agents
Helena J. Janse van Rensburg, Pavlina Spiliopoulou, Lillian L. Siu
The Oncologist (2022) Vol. 27, Iss. 5, pp. 352-362
Open Access | Times Cited: 13

Showing 13 citing articles:

Development of point-of-care tests for urinary bladder cancer – an historic review and view to future prospectives
Thorsten Ecke, Johan Styrke, Kiran Jagarlamudi, et al.
Urologic Oncology Seminars and Original Investigations (2025)
Closed Access
Stimulus-responsive smart bioactive glass composites for repair of complex tissue defects
Yulian Yang, Yonghao Qiu, Lin Cai, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1760-1786
Open Access
The Role of Cell-Free DNA in Cancer Treatment Decision Making
András Telekes, Anna Horváth
Cancers (2022) Vol. 14, Iss. 24, pp. 6115-6115
Open Access | Times Cited: 22
Exercise as cancer treatment: A clinical oncology framework for exercise oncology research
Kerry S. Courneya, Christopher M. Booth
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Potential Role of Tumor-Derived Exosomes in Non-Small-Cell Lung Cancer in the Era of Immunotherapy
Alfredo Tartarone, Rosa Lerose, Marina Tartarone, et al.
Life (2022) Vol. 12, Iss. 12, pp. 2104-2104
Open Access | Times Cited: 7
Targeted treatments after chemoradiotherapy failure in a patient with relapsed, advanced non‑small cell lung cancer with on‑therapy circulating tumor biomarker monitoring: A case report
Ying-hui Bi, Chaoran Xia, Xinglin Zhang, et al.
Oncology Letters (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 2
Antigen retrieval assisted electrochemiluminescence imaging of surface antigens at single tissue section
Chengfeng Fu, Dongni Han, Dechen Jiang, et al.
Electrochimica Acta (2023) Vol. 474, pp. 143550-143550
Closed Access | Times Cited: 2
Functional and quantitative evaluation of the 20S proteasome in serum and intracellular in145 moroccan patients with hematologic malignancies
Hassan Filali, Ouadie Mohamed El Yaagoubi, Ayoub Lahmadi, et al.
Clinical Proteomics (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Implementing and assessing Bayesian response-adaptive randomisation for backfilling in dose-finding trials
Lukas Pin, Sofía S. Villar, Hakim‐Moulay Dehbi
Contemporary Clinical Trials (2024) Vol. 142, pp. 107567-107567
Open Access
Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer
Patricia Mondelo‐Macía, Jorge García, Luís León, et al.
Molecular & Cellular Proteomics (2024) Vol. 23, Iss. 10, pp. 100834-100834
Open Access
Circulating biomarkers for diagnosis and response to therapies in cancer patients
Natália Marcéli Stefanes, Maria Eduarda Cunha-Silva, Lisandra de Oliveira Silva, et al.
International review of cell and molecular biology (2024), pp. 1-41
Closed Access
Integrated modeling of biomarkers, survival and safety in clinical oncology drug development
Han Liu, Eman Ibrahim, Maddalena Centanni, et al.
Advanced Drug Delivery Reviews (2024), pp. 115476-115476
Open Access
Microbiome and Metabolomic Biomarkers for Huntington’s Disease
Bethany A. Masson, Wendy Qin, Chloe J. Love, et al.
Contemporary clinical neuroscience (2023), pp. 247-273
Closed Access
Page 1

Scroll to top